Carol Ashe - Dec 28, 2023 Form 4 Insider Report for Elicio Therapeutics, Inc. (ELTX)

Role
Director
Signature
/s/ Carol Gail Ashe
Stock symbol
ELTX
Transactions as of
Dec 28, 2023
Transactions value $
$0
Form type
4
Date filed
12/29/2023, 05:05 PM
Previous filing
Jun 7, 2023
Next filing
Feb 7, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ELTX Stock Option (right to buy) Award $0 +4.1K $0.00 4.1K Dec 28, 2023 Common Stock 4.1K $8.26 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option, granted in lieu of the annual equity award under the Issuer's Amended and Restated Non-Employee Director Compensation Policy, vests in full on the earlier of (A) December 28, 2024, the one-year anniversary of the grant date, or (B) immediately prior to the next annual meeting of the Issuer's stockholders, subject to the Reporting Person continuing to provide services to the Issuer through such vesting date.